Follicular Lymphoma
2 competing products in clinical development for Follicular Lymphoma.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| CT-P10 + Rituxan | Celltrion | Phase 3 | Completed | 40 |
| DRL_RI (Proposed rituximab biosimilar) | Dr. Reddy's Laboratories | Phase 3 | Completed | 37 |